113 related articles for article (PubMed ID: 36923086)
1. Esophageal cancer-related gene 4 inhibits gastric cancer growth and metastasis by upregulating Krüppel-like factor 2 expression.
Li X; Hu S; Ma M; Wang P; Qi Y; Zhou Y; Zhong Z; Gao H; Bai F
Ann Transl Med; 2023 Feb; 11(4):176. PubMed ID: 36923086
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer.
You Y; Hu S
Cancer Biomark; 2022; 34(1):55-66. PubMed ID: 34657878
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-196b promotes gastric cancer progression by targeting ECRG4.
Chen L; Tang H; Liu G; Xiao S; Liang D; Ma J; Yang Y; Luo H; Zhu Y; Xie F; Cheng X; Chi J; Wu X
Anticancer Drugs; 2021 Feb; 32(2):127-137. PubMed ID: 33417325
[TBL] [Abstract][Full Text] [Related]
4. Expression of esophageal carcinoma related gene 4 (ECRG4) and its clinical significance in prognosis of esophageal carcinoma.
Wen Y; Hu X
Int J Clin Exp Pathol; 2015; 8(11):14772-8. PubMed ID: 26823803
[TBL] [Abstract][Full Text] [Related]
5. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
[TBL] [Abstract][Full Text] [Related]
6. Downregulation and DNA methylation of ECRG4 in gastric cancer.
Deng P; Chang XJ; Gao ZM; Xu XY; Sun AQ; Li K; Dai DQ
Onco Targets Ther; 2018; 11():4019-4028. PubMed ID: 30034241
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.
You Y; Li H; Qin X; Ran Y; Wang F
Cell Oncol (Dordr); 2016 Feb; 39(1):89-95. PubMed ID: 26631111
[TBL] [Abstract][Full Text] [Related]
8. Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation.
Luo L; Wu J; Xie J; Xia L; Qian X; Cai Z; Li Z
Tumour Biol; 2016 Jan; 37(1):1121-9. PubMed ID: 26276361
[TBL] [Abstract][Full Text] [Related]
9. Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients.
Chen JY; Wu X; Hong CQ; Chen J; Wei XL; Zhou L; Zhang HX; Huang YT; Peng L
Clin Transl Oncol; 2017 Jan; 19(1):84-90. PubMed ID: 27119734
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism driving poor-prognostic gastric cancer: overexpression of the transcription factor Krüppel-like factor 16 promotes growth and metastasis of gastric cancer through regulating the Notch pathway.
Sun DP; Tian YF; Lin CC; Hung ST; Uen YH; Hseu YC; Chou CL; Cheng LC; Wang WC; Kuang YY; Fang CL; Lin KY
Am J Cancer Res; 2021; 11(6):2717-2735. PubMed ID: 34249424
[TBL] [Abstract][Full Text] [Related]
11. ECRG4 as a novel tumor suppressor gene inhibits colorectal cancer cell growth in vitro and in vivo.
Cai Z; Liang P; Xuan J; Wan J; Guo H
Tumour Biol; 2016 Jul; 37(7):9111-20. PubMed ID: 26762416
[TBL] [Abstract][Full Text] [Related]
12. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.
Liu H; Zhao YR; Chen B; Ge Z; Huang JS
Cancer Manag Res; 2019; 11():3493-3509. PubMed ID: 31118775
[No Abstract] [Full Text] [Related]
13. A preliminary study of the effect of ECRG4 overexpression on the proliferation and apoptosis of human laryngeal cancer cells and the underlying mechanisms.
Jia J; Dai S; Sun X; Sang Y; Xu Z; Zhang J; Cui X; Song J; Guo X
Mol Med Rep; 2015 Oct; 12(4):5058-64. PubMed ID: 26165988
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
15. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
16. Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins.
Yuan L; Li JX; Yang Y; Chen Y; Ma TT; Liang S; Bu Y; Yu L; Nan Y
World J Gastroenterol; 2021 Apr; 27(16):1785-1804. PubMed ID: 33967557
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer.
Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL
BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858
[TBL] [Abstract][Full Text] [Related]
18. Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma.
Li L; Wang W; Li X; Gao T
Am J Transl Res; 2017; 9(8):3741-3748. PubMed ID: 28861165
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
Zhao EH; Shen ZY; Liu H; Jin X; Cao H
World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
[TBL] [Abstract][Full Text] [Related]
20. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
